Germline and somatic variations influence the somatic mutational signatures of esophageal squamous cell carcinomas in a Chinese population

Abstract

BackgroundEsophageal squamous cell carcinomas (ESCC) is the fourth most lethal cancer in China. Previous studies reveal several highly conserved mutational processes in ESCC. However, it remains unclear what are the true regulators of the mutational processes.ResultsWe analyzed the somatic mutational signatures in 302 paired whole-exome sequencing data of ESCC in a Chinese population for potential regulators of the mutational processes. We identified three conserved subtypes based on the mutational signatures with significantly different clinical outcomes. Our results show that patients of different subpopulations of Chinese differ significantly in the activity of the “NpCpG” signature (FDR = 0.00188). In addition, we report ZNF750 and CDC27, of which the somatic statuses and the genetic burdens consistently influence the activities of specific mutational signatures in ESCC: the somatic ZNF750 status is associated with the AID/APOBEC-related mutational process (FDR = 0.0637); the somatic CDC27 copy-number is associated with the “NpCpG” (FDR = 0.00615) and the AID/APOBEC-related mutational processes (FDR = 8.69 × 10− 4). The burdens of germline variants in the two genes also significantly influence the activities of the same somatic mutational signatures (FDR < 0.1).ConclusionsWe report multiple factors that influence the mutational processes in ESCC including: the subpopulations of Chinese; the germline and somatic statuses of ZNF750 and CDC27 and exposure to alcohol and tobacco. Our findings based on the evidences from both germline and somatic levels reveal potential genetic regulators of the somatic mutational processes and provide insights into the biology of esophageal carcinogenesis.Electronic supplementary materialThe online version of this article (10.1186/s12864-018-4906-4) contains supplementary material, which is available to authorized users.

CDC27 Promotes Tumor Progression and Affects PD-L1 Expression in T-Cell Lymphoblastic Lymphoma

“…However, this study also has some limitations. Firstly, in recent years, CDC27 mutations have been found in some cancers (44)(45)(46). A study has identified mutated CDC27 as a tumor antigen which leaded to massive changes of chromosomal number (47).…”

HiLDA: a statistical approach to investigate differences in mutational signatures

“…Previous studies interested in comparing mutational exposure estimates between different groups of tumor catalogs conducted a post hoc analysis (Cancer Genome Atlas Research Network, 2017; Chang et al, 2017; Hillman et al, 2017; Letouzé et al, 2017; Meier et al, 2018; Haradhvala et al, 2018; Qin et al, 2018; Olivier et al, 2019; Guo et al, 2018). The analysis proceeded in two stages.…”

The importance of CDC27 in cancer: molecular pathology and clinical aspects

“…Patients with Signature 1 showed low burden of overall somatic single nucleotide variants (SNVs). Inversely, higher burden of SNVs was significantly associated with CDC27 deletions [ 69 ].…”